The Form 4 filing, an SEC report of insider stock trades, was filed on October 13, 2026. The sale took place that same day. Cook Meredith is listed as a senior vice president, general counsel and secretary at ANI Pharmaceuticals (ANIP).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-13 |
| Date of Latest Transaction | 2026-10-13 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 500 |
| Price | $73.59 |
| Total Transaction Value | $36,795.00 |
| Insider | |
| Ticker Symbol | ANIP |
| Company | ANI PHARMACEUTICALS INC |
| Insider Name | Cook Meredith |
| Insider Title | SR. VP, GENERAL COUNSEL & SEC |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 73,424 |
| Position Size Change | 0.68% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, reported under transaction code S. The record lists one transaction.
What was the average price of the transaction?
The average sale price was $73.59 per share for the 500 shares sold.
How did this transaction affect the insider's holdings?
After selling 500 shares, Cook Meredith reported 73,424 shares remaining. The sale represented 0.68% of the shares held before the sale.
What's the total transaction value?
The total sale value was $36,795.00. That amount covers the single reported transaction involving 500 shares.
Are there any special circumstances around this transaction?
The transaction information includes a reference to a Rule 10b5-1 trading plan. These plans set trading instructions in advance. No filing footnotes were provided, so it is unclear whether the reference covers this specific sale or the filing as a whole. The plan's terms, start date and trading schedule remain unknown. The reference alone does not establish the reason for the sale.
For research purposes only; not investment advice.